Published in Environ Health Perspect on April 01, 1997
Evaluating the effects of endocrine disruptors on endocrine function during development. Environ Health Perspect (1999) 1.36
Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994. Environ Health Perspect (2000) 1.09
Evidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action. Reprod Biol Endocrinol (2005) 0.88
Simultaneous Measurement of 17β-Estradiol, 17α-Estradiol and Estrone by GC-Isotope Dilution MS/MS. Chromatographia (2010) 0.84
It's time to rethink dose: the case for combining cancer and birth and developmental defects. Environ Health Perspect (2001) 0.83
Long-term effects of neonatal exposure to hydroxylated polychlorinated biphenyls in the BALB/cCrgl mouse. Environ Health Perspect (2005) 0.76
Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst (1993) 8.11
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology (1992) 1.45
Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol (1988) 1.22
Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. Crit Rev Oncol Hematol (1992) 1.13
Genotoxic effects of estrogens. Mutat Res (1990) 1.11
Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res (1983) 1.02
2-Fluoroestradiol. Separation of estrogenicity from carcinogenicity. Mol Pharmacol (1983) 0.98
Mitotic inhibition and aneuploidy induction by naturally occurring and synthetic estrogens in Chinese hamster cells in vitro. Mutat Res (1986) 0.95
Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res (1987) 0.92
Effects of estradiol-17 alpha on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. J Steroid Biochem (1982) 0.91
Regulation of prolactin production and cell growth by estradiol: difference in sensitivity to estradiol occurs at level of messenger ribonucleic acid accumulation. Endocrinology (1987) 0.91
Strain differences in the ontogeny of estrogen receptors in murine uterine epithelium. Endocrinology (1990) 0.90
Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Res (1985) 0.89
Alteration of proto-oncogene c-fos expression in neonatal estrogenized BALB/c female mice & murine cervicovaginal tumor LJ6195. Endocrinology (1991) 0.88
Interaction of ring B unsaturated estrogens with estrogen receptors of human endometrium and rat uterus. Steroids (1991) 0.83
Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. Cancer Res (1981) 0.83
Role of chemically induced mutagenic events in neoplastic transformation of Syrian hamster embryo cells. Carcinog Compr Surv (1985) 0.83
Effects of estrogenic chemicals on development. Environ Health Perspect (1995) 0.82
In vivo induction of increased DNA ploidy of mouse cervicovaginal epithelium by neonatal estrogen treatment. Biol Reprod (1993) 0.82
Genotoxic effects of estrogens in epithelial cells from the neonatal mouse uterine cervix: modifications by metabolic modifiers. Teratog Carcinog Mutagen (1989) 0.82
The development of the role of hormones in development--a double remembrance. Endocrinology (1992) 0.81
Characterization and partial purification of an estrogen type II binding site in chick oviduct cytosol. Biochemistry (1989) 0.80
Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia. Cancer Res (1988) 0.80
Superinduction of c-fos gene expression by estrogen in cultured guinea-pig endometrial cells requires priming by a cycloheximide-dependent mechanism. Endocrinology (1992) 0.79
Progesterone metabolism by cultured Sertoli cells. Endocrinology (1978) 0.78
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 31.55
Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol (2001) 10.39
High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry (1999) 5.54
Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med (1997) 3.62
The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. N Engl J Med (1998) 3.40
Communication within the emergency department: how do you get the word out? J Emerg Nurs (1994) 3.29
Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry (1999) 3.07
In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J Exp Med (1990) 2.69
Induction of cyclin D1 overexpression by activated ras. Oncogene (1994) 2.35
Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations. Mutat Res (1987) 2.31
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest (1997) 2.29
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
Tumor scanning with 67Ga citrate. J Nucl Med (1969) 2.18
The effect of continuous epidural analgesia on cesarean section for dystocia in nulliparous women. Am J Obstet Gynecol (1989) 2.17
A natural history of cleidocranial dysplasia. Am J Med Genet (2001) 2.14
Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci U S A (1998) 2.10
The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br J Pharmacol (1989) 2.09
Polydactyly and psychosis. Five cases of co-occurrence. Br J Psychiatry (1998) 2.02
Didelphic uterus and obstructed hemivagina with renal agenesis: case report and review of the literature. J Pediatr Adolesc Gynecol (2004) 2.01
Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer. J Natl Cancer Inst (1996) 1.99
Separation of spermatogenic cells and nuclei from rodent testes. Methods Cell Biol (1977) 1.97
Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: a multicenter prospective assessment. Virginia Thrombolytic Study Group. Ann Emerg Med (1992) 1.97
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog (1999) 1.95
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev (1998) 1.88
The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab (1992) 1.86
Cellular DNA content as a marker of human multiple myeloma. Blood (1980) 1.83
Antinuclear antibodies and breast implants. West J Med (1994) 1.77
Abnormal spermatogenesis and reduced fertility in transition nuclear protein 1-deficient mice. Proc Natl Acad Sci U S A (2000) 1.76
Sohlh1 is essential for spermatogonial differentiation. Dev Biol (2006) 1.74
The phylogeny of the Schistosomatidae based on three genes with emphasis on the interrelationships of Schistosoma Weinland, 1858. Parasitology (2003) 1.74
Guidelines for bacteriophage characterization. Adv Virus Res (1978) 1.66
Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg (1995) 1.66
Expanded CAG repeats in schizophrenia and bipolar disorder. Nat Genet (1995) 1.66
Uncertainty analysis of absorbed dose calculations from thermoluminescence dosimeters. Med Phys (1993) 1.65
Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr (1990) 1.64
Identification of the V factor needed for synthesis of the iron-molybdenum cofactor of nitrogenase as homocitrate. Nature (1987) 1.64
Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer (2000) 1.63
Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med (1994) 1.63
Cellular DNA content as a marker of neoplasia in man. Am J Med (1980) 1.62
Ophthalmic microsurgical robot and associated virtual environment. Comput Biol Med (1995) 1.62
VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene (1998) 1.61
Thymic requirement for clonal deletion during T cell development. Science (1989) 1.60
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res (1999) 1.60
Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumor specimens by the polymerase chain reaction. Am J Pathol (1991) 1.59
Cancer mortality in Menofeia, Egypt: comparison with US mortality rates. Cancer Causes Control (1999) 1.59
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res (2001) 1.59
High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature (1995) 1.57
Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet (1997) 1.57
Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. Br J Psychiatry (2001) 1.56
Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia (1995) 1.55
p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst (1993) 1.54
Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol (1998) 1.54
A randomized trial comparing heater probe plus thrombin with heater probe plus placebo for bleeding peptic ulcer. Gastroenterology (2003) 1.54
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Coll Cardiol (1998) 1.53
Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer (1989) 1.52
Perception of force and weight: theory and research. Psychol Bull (1986) 1.51
Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci U S A (1996) 1.51
Phylogenies inferred from mitochondrial gene orders-a cautionary tale from the parasitic flatworms. Mol Biol Evol (2000) 1.50
Biochemical analysis of the stress protein response in human oesophageal epithelium. Gut (1997) 1.50
Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med (1996) 1.49
Thermodynamics of unfolding for turkey ovomucoid third domain: thermal and chemical denaturation. Protein Sci (1993) 1.48
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med (2002) 1.47
Optimization of prostate biopsy strategy using computer based analysis. J Urol (1997) 1.47
p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential. J Urol (1999) 1.46
The species concept and its application to tailed phages. Arch Virol (1992) 1.45
p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999) 1.45
The changing spectrum of gastroesophageal reflux disease. Eur J Cancer Prev (2002) 1.44
Extramammary Paget's disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys (1992) 1.44
Biosynthesis of lipopolysaccharide in Escherichia coli. Cytoplasmic enzymes that attach 3-deoxy-D-manno-octulosonic acid to lipid A. J Biol Chem (1989) 1.43
Extensive subcutaneous metastases from squamous cell carcinoma of the cervix in patient with HIV. Int J Gynecol Cancer (2001) 1.42
Comparison of the efficacies of disinfectants to control microbial contamination in dental unit water systems in general dental practices across the European Union. Appl Environ Microbiol (2006) 1.42
Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: validation in humans. J Am Coll Cardiol (1993) 1.39
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A (1998) 1.38
Targeted disruption of the transition protein 2 gene affects sperm chromatin structure and reduces fertility in mice. Mol Cell Biol (2001) 1.38
A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet (1999) 1.37
Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37
Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations. Int J Radiat Oncol Biol Phys (1995) 1.37
Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res (1995) 1.36
Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res (1982) 1.35
Cytotoxic effects of chemotherapeutic drugs on mouse testis cells. Cancer Res (1979) 1.33
Semiquantitative oropharyngeal culture technique. Appl Microbiol (1970) 1.33
pH, ionic strength, and temperature dependences of ionization equilibria for the carboxyl groups in turkey ovomucoid third domain. Biochemistry (1995) 1.33
Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res (1995) 1.32
Biosynthesis of lipid A in Escherichia coli: identification of UDP-3-O-[(R)-3-hydroxymyristoyl]-alpha-D-glucosamine as a precursor of UDP-N2,O3-bis[(R)-3-hydroxymyristoyl]-alpha-D-glucosamine. Biochemistry (1988) 1.32
A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution. Proc Natl Acad Sci U S A (2000) 1.32
Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med (2001) 1.31
Mutagenic effects of thymine dimers in bacteriophage T4. J Mol Biol (1972) 1.31
Temperature and pH dependences of hydrogen exchange and global stability for ovomucoid third domain. Biochemistry (1996) 1.30
Purification of rat spermatogenic cells and preliminary biochemical analysis of these cells. Biol Reprod (1981) 1.29
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol (1999) 1.29
The Fas system, a regulator of testicular germ cell apoptosis, is differentially up-regulated in Sertoli cell versus germ cell injury of the testis. Endocrinology (1999) 1.29
Myopia and ambient night-time lighting. CLEERE Study Group. Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error. Nature (2000) 1.29
Gradual regeneration of mouse testicular stem cells after exposure to ionizing radiation. Radiat Res (1978) 1.28
Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer (1992) 1.28
Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. Nat Genet (2001) 1.28
Does maintenance therapy keep duodenal ulcers healed? Lancet (1988) 1.28
67Ga-citrate imaging in untreated Hodgkin's disease: preliminary report of Cooperative Group. J Nucl Med (1974) 1.28
Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery (1994) 1.28
No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry (1996) 1.28